Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
NCT ID:
NCT03403634
Group ID:
EG000
Title:
Treatment (Celecoxib, Interferon Alfa-2b, Rintatolimod)
Description:
Patients receive celecoxib orally PO BID, recombinant interferon alfa-2b IV QD over 20 minutes, and rintatolimod IV QD on days 1, 2, 3, 8, 9, 10, 15, 16 and 17 in the absence of disease progression or unacceptable toxicity.
Celecoxib: Given PO
Laboratory Biomarker Analysis: Correlative studies
Recombinant Interferon Alfa-2b: Given IV
Rintatolimod: Given IV
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
15
Other Number Affected:
14
Other Number At Risk:
15
Study:
NCT03403634
Results Section:
NCT03403634
Adverse Events Module:
NCT03403634